Ethics and drug resistance : : collective responsibility for global public health / / editors, Euzebiusz Jamrozik, Michael Selgelid.
This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major t...
Saved in:
Superior document: | Public Health Ethics Analysis, 5 |
---|---|
: | |
HerausgeberIn: | |
Place / Publishing House: | Cham : : Springer International Publishing :, Imprint: Springer,, 2020. |
Year of Publication: | 2020 |
Edition: | 1st edition 2020. |
Language: | English |
Series: | Public Health Ethics Analysis,
5 |
Physical Description: | 1 online resource (XVII, 448 p. 1 illus.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544115104498 |
---|---|
ctrlnum |
(CKB)4100000011528372 (DE-He213)978-3-030-27874-8 (MiAaPQ)EBC6381407 (Au-PeEL)EBL6381407 (OCoLC)1239982305 (oapen)https://directory.doabooks.org/handle/20.500.12854/64401 (EXLCZ)994100000011528372 |
collection |
bib_alma |
record_format |
marc |
spelling |
Giubilini, Alberto auth Ethics and drug resistance : collective responsibility for global public health / editors, Euzebiusz Jamrozik, Michael Selgelid. 1st edition 2020. Springer Nature 2020 Cham : Springer International Publishing : Imprint: Springer, 2020. 1 online resource (XVII, 448 p. 1 illus.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Public Health Ethics Analysis, 2211-6680 ; 5 This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century. Introduction -- Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance -- Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu) -- Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson) -- Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij) -- Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx) -- Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley) -- Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug) -- Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid) -- Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe) -- Part 2 Ethics and antimicrobial resistance in context -- Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge) -- Chapter 10 Antibiotic use in childhood (Michael Millar) -- Chapter 11 Ethics, animals, public goods (Jonny Anomaly) -- Chapter 12 Malaria (PY Cheah& Mike Parker) -- Chapter 13 Resistant HIV (Bridget Haire) -- Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann) -- Chapter 15 TB Resistance and Human rights (Leslie London) -- Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan) -- Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor) -- Part 3 Ethical, legal and economic aspects of antimicrobial resistance -- Chapter 18 Privacy and data collection(Leslie Francis) -- Chapter 19 Mandatory treatment interventions (Carl Coleman) -- Chapter 20 Ethics and AMR Regulation (Belinda Bennett) -- Chapter 21 Ethics of Drug Development (Nick King) -- Chapter 22 Economics of resistance (Coast/Smith) -- Conclusion. Open Access Description based on publisher supplied metadata and other sources. English Bioethics. Drug resistance. Communicable diseases. Bioethics · Public health ethics · Antimicrobial resistance · Collective responsibility · Easy rescue 3-030-27873-5 Jamrozik, Euzebiusz. editor. edt http://id.loc.gov/vocabulary/relators/edt Selgelid, Michael J. editor. edt http://id.loc.gov/vocabulary/relators/edt |
language |
English |
format |
eBook |
author |
Giubilini, Alberto |
spellingShingle |
Giubilini, Alberto Ethics and drug resistance : collective responsibility for global public health / Public Health Ethics Analysis, Introduction -- Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance -- Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu) -- Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson) -- Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij) -- Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx) -- Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley) -- Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug) -- Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid) -- Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe) -- Part 2 Ethics and antimicrobial resistance in context -- Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge) -- Chapter 10 Antibiotic use in childhood (Michael Millar) -- Chapter 11 Ethics, animals, public goods (Jonny Anomaly) -- Chapter 12 Malaria (PY Cheah& Mike Parker) -- Chapter 13 Resistant HIV (Bridget Haire) -- Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann) -- Chapter 15 TB Resistance and Human rights (Leslie London) -- Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan) -- Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor) -- Part 3 Ethical, legal and economic aspects of antimicrobial resistance -- Chapter 18 Privacy and data collection(Leslie Francis) -- Chapter 19 Mandatory treatment interventions (Carl Coleman) -- Chapter 20 Ethics and AMR Regulation (Belinda Bennett) -- Chapter 21 Ethics of Drug Development (Nick King) -- Chapter 22 Economics of resistance (Coast/Smith) -- Conclusion. |
author_facet |
Giubilini, Alberto Jamrozik, Euzebiusz. Jamrozik, Euzebiusz. Selgelid, Michael J. Selgelid, Michael J. |
author_variant |
a g ag |
author2 |
Jamrozik, Euzebiusz. Jamrozik, Euzebiusz. Selgelid, Michael J. Selgelid, Michael J. |
author2_variant |
e j ej e j ej m j s mj mjs m j s mj mjs |
author2_role |
HerausgeberIn HerausgeberIn HerausgeberIn HerausgeberIn |
author_sort |
Giubilini, Alberto |
title |
Ethics and drug resistance : collective responsibility for global public health / |
title_sub |
collective responsibility for global public health / |
title_full |
Ethics and drug resistance : collective responsibility for global public health / editors, Euzebiusz Jamrozik, Michael Selgelid. |
title_fullStr |
Ethics and drug resistance : collective responsibility for global public health / editors, Euzebiusz Jamrozik, Michael Selgelid. |
title_full_unstemmed |
Ethics and drug resistance : collective responsibility for global public health / editors, Euzebiusz Jamrozik, Michael Selgelid. |
title_auth |
Ethics and drug resistance : collective responsibility for global public health / |
title_new |
Ethics and drug resistance : |
title_sort |
ethics and drug resistance : collective responsibility for global public health / |
series |
Public Health Ethics Analysis, |
series2 |
Public Health Ethics Analysis, |
publisher |
Springer Nature Springer International Publishing : Imprint: Springer, |
publishDate |
2020 |
physical |
1 online resource (XVII, 448 p. 1 illus.) |
edition |
1st edition 2020. |
contents |
Introduction -- Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance -- Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu) -- Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson) -- Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij) -- Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx) -- Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley) -- Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug) -- Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid) -- Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe) -- Part 2 Ethics and antimicrobial resistance in context -- Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge) -- Chapter 10 Antibiotic use in childhood (Michael Millar) -- Chapter 11 Ethics, animals, public goods (Jonny Anomaly) -- Chapter 12 Malaria (PY Cheah& Mike Parker) -- Chapter 13 Resistant HIV (Bridget Haire) -- Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann) -- Chapter 15 TB Resistance and Human rights (Leslie London) -- Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan) -- Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor) -- Part 3 Ethical, legal and economic aspects of antimicrobial resistance -- Chapter 18 Privacy and data collection(Leslie Francis) -- Chapter 19 Mandatory treatment interventions (Carl Coleman) -- Chapter 20 Ethics and AMR Regulation (Belinda Bennett) -- Chapter 21 Ethics of Drug Development (Nick King) -- Chapter 22 Economics of resistance (Coast/Smith) -- Conclusion. |
isbn |
3-030-27874-3 3-030-27873-5 |
issn |
2211-6680 ; |
callnumber-first |
Q - Science |
callnumber-subject |
QH - Natural History and Biology |
callnumber-label |
QH332 |
callnumber-sort |
QH 3332 |
illustrated |
Illustrated |
dewey-hundreds |
100 - Philosophy & psychology |
dewey-tens |
170 - Ethics |
dewey-ones |
171 - Ethical systems |
dewey-full |
171.7 |
dewey-sort |
3171.7 |
dewey-raw |
171.7 |
dewey-search |
171.7 |
oclc_num |
1239982305 |
work_keys_str_mv |
AT giubilinialberto ethicsanddrugresistancecollectiveresponsibilityforglobalpublichealth AT jamrozikeuzebiusz ethicsanddrugresistancecollectiveresponsibilityforglobalpublichealth AT selgelidmichaelj ethicsanddrugresistancecollectiveresponsibilityforglobalpublichealth |
status_str |
n |
ids_txt_mv |
(CKB)4100000011528372 (DE-He213)978-3-030-27874-8 (MiAaPQ)EBC6381407 (Au-PeEL)EBL6381407 (OCoLC)1239982305 (oapen)https://directory.doabooks.org/handle/20.500.12854/64401 (EXLCZ)994100000011528372 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Public Health Ethics Analysis, 5 |
hierarchy_sequence |
5 |
is_hierarchy_title |
Ethics and drug resistance : collective responsibility for global public health / |
container_title |
Public Health Ethics Analysis, 5 |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField noLinkedField |
_version_ |
1796651906266824704 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04623nam a22004935i 4500</leader><controlfield tag="001">993544115104498</controlfield><controlfield tag="005">20220914220914.0</controlfield><controlfield tag="006">m o d | </controlfield><controlfield tag="007">cr#nn#---mamaa</controlfield><controlfield tag="008">201026s2020 sz a o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-030-27874-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/978-3-030-27874-8</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000011528372</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-He213)978-3-030-27874-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(MiAaPQ)EBC6381407</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(Au-PeEL)EBL6381407</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1239982305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/64401</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000011528372</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">MiAaPQ</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="e">pn</subfield><subfield code="c">MiAaPQ</subfield><subfield code="d">MiAaPQ</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QH332</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PSAD</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PHI005000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">PSAD</subfield><subfield code="2">thema</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">171.7</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Giubilini, Alberto</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ethics and drug resistance :</subfield><subfield code="b">collective responsibility for global public health /</subfield><subfield code="c">editors, Euzebiusz Jamrozik, Michael Selgelid.</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">1st edition 2020.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Springer Nature</subfield><subfield code="c">2020</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cham :</subfield><subfield code="b">Springer International Publishing :</subfield><subfield code="b">Imprint: Springer,</subfield><subfield code="c">2020.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (XVII, 448 p. 1 illus.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Public Health Ethics Analysis,</subfield><subfield code="x">2211-6680 ;</subfield><subfield code="v">5</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">This Open Access volume provides in-depth analysis of the wide range of ethical issues associated with drug-resistant infectious diseases. Antimicrobial resistance (AMR) is widely recognized to be one of the greatest threats to global public health in coming decades; and it has thus become a major topic of discussion among leading bioethicists and scholars from related disciplines including economics, epidemiology, law, and political theory. Topics covered in this volume include responsible use of antimicrobials; control of multi-resistant hospital-acquired infections; privacy and data collection; antibiotic use in childhood and at the end of life; agricultural and veterinary sources of resistance; resistant HIV, tuberculosis, and malaria; mandatory treatment; and trade-offs between current and future generations. As the first book focused on ethical issues associated with drug resistance, it makes a timely contribution to debates regarding practice and policy that are of crucial importance to global public health in the 21st century.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Introduction -- Part 1 Theoretical and conceptual approaches to ethics in antimicrobial resistance -- Chapter 1 The practical ethics of antimicrobial resistance as a collective action problem (Julian Savulescu) -- Chapter 2 Collective responsibility for antimicrobial resistance (Angus Dawson) -- Chapter 3 Moral aspects of antimicrobial stewardship (Marcel Verweij) -- Chapter 4 Ethical frameworks for rational antibiotic use (Annette Rid, Jasper Littmann, Alena Buyx) -- Chapter 5 The virtuous physician as antimicrobial prescriber (Justin Oakley) -- Chapter 6 Solidarity and compliance with antimicrobial policy (Søren Holm, Thomas Ploug) -- Chapter 7 Resistance, inequality, and epidemiological transition (Lynette Reid) -- Chapter 8 The price of precaution (Joakim Larsson, Christian Munthe) -- Part 2 Ethics and antimicrobial resistance in context -- Chapter 9 Hospital acquired infection (Lyn Gilbert & Ian Kerridge) -- Chapter 10 Antibiotic use in childhood (Michael Millar) -- Chapter 11 Ethics, animals, public goods (Jonny Anomaly) -- Chapter 12 Malaria (PY Cheah& Mike Parker) -- Chapter 13 Resistant HIV (Bridget Haire) -- Chapter 14 Access & availability of new TB drugs (Diego Silva, Adrian Viens, Jasper Littmann) -- Chapter 15 TB Resistance and Human rights (Leslie London) -- Chapter 16 TB Resistance in developing countries (Richard Coker, Marco Liverani, Mishal Khan) -- Chapter 17 Animal Epidemiology (Lisa Boden & Dominic Mellor) -- Part 3 Ethical, legal and economic aspects of antimicrobial resistance -- Chapter 18 Privacy and data collection(Leslie Francis) -- Chapter 19 Mandatory treatment interventions (Carl Coleman) -- Chapter 20 Ethics and AMR Regulation (Belinda Bennett) -- Chapter 21 Ethics of Drug Development (Nick King) -- Chapter 22 Economics of resistance (Coast/Smith) -- Conclusion.</subfield></datafield><datafield tag="506" ind1="0" ind2=" "><subfield code="a">Open Access</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Bioethics.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug resistance.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Communicable diseases.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Bioethics · Public health ethics · Antimicrobial resistance · Collective responsibility · Easy rescue</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-030-27873-5</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jamrozik, Euzebiusz.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Selgelid, Michael J.</subfield><subfield code="e">editor.</subfield><subfield code="4">edt</subfield><subfield code="4">http://id.loc.gov/vocabulary/relators/edt</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Public Health Ethics Analysis,</subfield><subfield code="x">2211-6680 ;</subfield><subfield code="v">5</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 20:38:10 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-11-07 22:10:03 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339658200004498&Force_direct=true</subfield><subfield code="Z">5339658200004498</subfield><subfield code="b">Available</subfield><subfield code="8">5339658200004498</subfield></datafield></record></collection> |